Dendreon (DNDN) says FDA approved the rest of its New Jersey manufacturing sites, expanding the launch of Provenge
Tweet Send to a FriendGet Alerts DNDN Hot Sheet
Down)
Trade DNDN Now!
Dendreon (Nasdaq: DNDN) says the FDA has approved the rest of its New Jersey manufacturing sites, expanding the launch of Provenge
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Cardiovascular Systems (CSII) ORBIT II Trial Met Endpoints
- EMA Approves MAA for Gilead's (GILD) Sofosbuvir
- Salix Pharma (SLXP) Reports Positive Results From Two Budesonide Foam Phase 3s
Create E-mail Alert Related Categories
Corporate News, FDA, Momentum Movers
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
